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According to current models of retrovirus infection, receptor binding to the surface subunit (SU) of the envelope
glycoprotein (Env) triggers a conformational change in the transmembrane subunit (TM) that mediates virus fusion to
cell membranes. To understand how this occurs, we investigated the role of the receptor Tva in avian leukosis virus-A
(ALV-A) infection. We find that Tva binding induced the formation of a reactive thiolate on Cys38 (Cys38-S
 ) in SU. Both
chemical and genetic inactivation of Cys38-S
  completely abrogated ALV fusion and infection. Remarkably, Cys38-S
 
does not mediate isomerization of the SU-TM disulfide bond and is not required for Tva-induced activation of TM,
including pre-hairpin association with membranes and low pH assembly of helical bundles. These findings indicate
that, contrary to current models, receptor activation of TM is not sufficient for ALV fusion and infection and that
formation of a reactive thiolate is an additional receptor-dependent step.
Citation: Smith JG, Cunningham JM (2007) Receptor-induced thiolate couples Env activation to retrovirus fusion and infection. PLoS Pathog 3(12): e198. doi:10.1371/journal.
ppat.0030198
Introduction
Enveloped virus infection is mediated by glycoproteins
that protrude from the virus membrane. There are striking
structural and functional similarities among the envelope
glycoproteins (Envs) of ortho-, paramyxo-, retro-, ﬁlo-, and
coronaviruses. As such, they are considered together as class I
Envs [1]. Class I Envs are trimers of dimers composed of
transmembrane (TM) and membrane distal subunits. The
‘‘spring-loaded’’ hypothesis has been proposed to explain the
structural rearrangements of class I Envs required for fusion
and infection [2]. According to this model, the conformation
of TM in mature Env trimer is metastable, but is kinetically
trapped by close association with membrane distal subunits.
Upon encountering a target cell, the stabilizing contacts
between subunits are disrupted, and completion of TM
folding is favored. In particular, the N-terminal segment of
TM containing the fusion peptide is exposed and inserts into
target cell and/or virus membranes (pre-hairpin conforma-
tion), and a highly stable helical bundle containing a central
coiled coil is formed [3]. It is proposed that formation of the
helical bundle functions as a zipper to bring virus and cell
membranes into proximity and to promote membrane lipid
exchange [4,5]. In support of the spring-loaded model,
elevated temperature or chemical denaturing agents mimic
the actions of physiological factors, such as receptor binding
and/or low pH, in triggering helical bundle formation [2,6].
Stabilization of the pre-fusion conformation of TM is an
essential function of membrane distal subunits of class I
Envs.
In addition to stabilizing pre-fusion TM, the membrane
distal subunit is also the sensor for the physiological factors
that trigger infection. For retroviruses, these factors are
membrane proteins or receptors that bind to the membrane
distal or surface subunit (SU). Discrete receptors have been
identiﬁed for nearly all classes of retroviruses, and the basis
for receptor-Env binding has been extensively analyzed [7].
These studies exclude a simple model in which receptor
binding merely mediates virus attachment and trafﬁcking to a
speciﬁc membrane compartment. In this regard, the function
of retrovirus receptors is distinct from that of sialoproteins
that bind to the inﬂuenza hemagglutinin (HA) [8]. Compara-
tive analyses of retrovirus receptors have not revealed
common properties that are necessary for infection. How-
ever, there are common features among retrovirus Envs that
provide clues to the mechanism of receptor function. For
example, the regions of HIV gp120 and MLV gp70 that bind
to receptor are distinct from regions that stabilize the pre-
fusion conformation of TM [9–13]. Therefore, a simple lock-
and-key model in which receptor directly binds and releases
the TM ‘‘clamp’’ is not supported. Rather, the studies of HIV
and MLV infection indicate the existence of multi-step
triggering mechanisms, which may reduce the probability of
premature activation and protect the essential elements of
Env from immune recognition.
For avian alpharetroviruses, a structural correlate is
lacking; however, there is functional evidence for a multi-
step triggering mechanism [14]. In particular, receptor
binding is necessary but not sufﬁcient for infection, which
requires exposure of receptor-bound Env to low pH in
endosomes [15]. An important goal is to understand how
receptor binding is coupled to fusion activation. To this end,
we pursued studies to identify receptor-induced intermediate
states in ALV-A Env. We observe that receptor binding
induces formation of a cysteine thiolate (Cys-S
 ) in SU that is
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critical Cys-S
 , membrane fusion and infection are un-
coupled from TM activation, thus revealing a previously
unidentiﬁed role for SU in ALV infection.
Results
Receptor-Dependent Inhibition of ALV-A Infection by
Thiol-Specific Alkylating Agents
The thiol-speciﬁc alkylating reagent, PEO-maleimide bio-
tin (PMB), was used to probe for functionally important
thiolates in ALV-A. Puriﬁed ALV-A virus particles were
incubated with PMB for 30 min at 37 8C, and infectivity was
measured on human 293 cells expressing the ALV receptor
Tva (293-Tva). PMB treatment alone had little or no effect on
ALV-A infection under these conditions. However, exposure
of ALV-A particles to PMB (10 mM) in the presence of sTva, a
functional isoform of the ALV-A receptor lacking the
transmembrane domain, reduced infection by .99% (Figure
1). In contrast, MLV particles were mildly sensitive to PMB,
and this effect was not altered by the presence of sTva.
Similar results were obtained with the thiol-reactive reagents
DTNB (Ellman’s reagent) and PEO-iodoacetyl biotin (data not
shown). These ﬁndings strongly suggest the existence of
functionally important cysteine thiolate(s) in ALV-A.
Because PMB is membrane impermeable and its inhibitory
activity is sTva-dependent, the suspected PMB target is the
ALV-A Env glycoprotein. To test this hypothesis, we studied
chimeric virus particles in which ALV Env was expressed on
MLV particles. The effect of PMB treatment of these particles
was comparable to native MLV particles. However, PMB
treatment in the presence of sTva reduced infectivity to less
than 0.001% (Figure 1). These ﬁndings suggest that Tva
binding creates or exposes a functionally important cysteine
thiolate (Cys-S
 ) target for PMB in ALV-A Env. The marked
sensitivity of the chimeric particles to PMB inhibitor
compared to ALV-A may reﬂect poor incorporation of
ALV-A Env into MLV particles and/or a synergistic effect of
PMB on ALV-A Env and MLV core.
SU Contains the Cys-S
  Target for Modification by PMB
The modiﬁcation of reactive Cys-S
  by PMB is irreversible.
To identify the PMB target, Env was recovered from lysates of
PMB-treated ALV-A by immunoprecipitation using an anti-
TM antibody and reduced and denatured subunits were
probed for the biotin moiety using streptavidin-HRP. Viruses
exposed to 1 mM sulfo-NHS-biotin (SNB), which reacts with
primary amines, served as a control. SU and TM were the
predominant targets for covalent modiﬁcation by SNB
(Figure 2A), and the presence of sTva did not noticeably
alter labeling, recovery, or detection of SNB-modiﬁed viral
proteins. In contrast, modiﬁcation of ALV-A Env by PMB was
Tva-dependent and limited to a single 70 kDa viral protein
(Figure 2A). The apparent molecular weight of the PMB-
modiﬁed protein was reduced from 70 kDa to 45 kDa by
treatment to remove N-linked glycans using the enzyme
PNGase F (data not shown). In addition, the PMB-labeled
protein was immunoprecipitated by the ALV-A SU-speciﬁc
mAb mc8C5 (data not shown). These ﬁndings strongly suggest
that one or more cysteine thiolates in ALV-A SU are the
targets for Tva-dependent modiﬁcation by PMB.
Identification of Essential Cys-S
  Residues in ALV-A Env
To identify the cysteine thiolate targets in ALV-SU, LCQ-
MS/MS was performed. SU for this analysis was derived from
puriﬁed virions that were incubated with the thiol-alkylating
agent, N-ethylmaleimide (NEM), in the presence of sTva.
NEM-modiﬁed SU was puriﬁed from virions, and N-linked
carbohydrates were removed using PNGase F. The deglyco-
sylation reaction products were resolved by SDS-PAGE and
quantiﬁed by SYPRO Ruby staining (Figure 2B). The portion
of the gel containing NEM-modiﬁed SU was excised, and SU
was subjected to in-gel proteolytic digestion and LCQ-MS/MS
analysis. This analysis identiﬁed peptide fragments contain-
ing 97% of all residues in SU including all of the cysteine
Figure 1. PMB Inhibition of ALV-A Infection Is Tva-Dependent and Maps
to Env
ALV-A or chimeric ALV-A/MLV virus was exposed to increasing
concentrations of PMB in the presence or absence of 10 lM sTva. Virus
titers were determined by endpoint dilution after spinoculation on 293-
Tva cells. As a control, MLV was exposed to increasing concentrations of
PMB in the presence or absence of 10 lM sTva, and virus titers were
determined by endpoint dilution after spinoculation on 293-mCAT cells.
*Virus titer was undetectable under these conditions.
doi:10.1371/journal.ppat.0030198.g001
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Author Summary
Many pathogenic viruses including retroviruses, ebolavirus, and
SARS have adopted similar ways to enter cells. According to current
models of infection, the envelope glycoproteins (Env) of these
viruses are activated by their encounter with specific receptor
proteins on target cells. In this scheme, receptor binding to the
glycoprotein surface subunit releases constraints on the intrinsic
membrane fusion activity of the transmembrane subunit. New
studies summarized in this report have examined the chemical basis
for receptor activation of avian retrovirus envelope glycoproteins.
They show that receptor binding creates a reactive cysteine thiolate
in the surface subunit that is essential for infection. Remarkably, this
cysteine thiolate is not required to activate the known steps in
infection mediated by the transmembrane subunit, including
insertion into the target membrane and assembly into helical
bundles. Thus, the receptor-induced cysteine thiolate mediates a
key step in infection that is not accounted for by current models of
Env function.residues. Peptide fragments containing NEM-modiﬁed SU
Cys38, Cys292, and Cys309 were identiﬁed (Figure 2C and
2D). These results conclusively demonstrate that Cys-S
 
residues in SU are targets for sTva-dependent modiﬁcation
by thiol-reactive agents.
The Thiol Group of Cys38 Is Essential for ALV-A Infection
To further investigate the role of reactive thiols in
infection, mutant Envs in which the Cys residues in SU
including Cys38, Cys292, and Cys309 were replaced with
serine were prepared and analyzed. The env genes bearing
individual Cys to Ser substitutions were inserted into an ALV-
A provirus, RCASBP(A), that encodes enhanced green
ﬂuorescent protein (EGFP) as a marker for infection. Each
provirus was then transfected into avian DF-1 cells, and the
production of replication-competent virus was monitored by
the spread of EGFP expression in the culture. Viruses bearing
the C60S or C91S substitutions were infectious and indis-
tinguishable from wild type ALV in all assays and were not
studied further (Figure 3). The 12 remaining mutant viruses
were non-infectious, and 11, including Cys292Ser and
Cys309Ser, were defective for Env processing and incorpo-
ration into virions. However, Cys38Ser did not alter Env
processing. Extensive studies did not identify any detectable
difference in the processing, cleavage or virus incorporation
between wild type and Cys38Ser Env (data not shown). DF-1
cells producing ALV-A Cys38Ser particles were maintained in
culture for months without reverting to infectious virus.
Moreover, transient expression of wild type ALV-A Env in
these cells rapidly restored production of fully infectious
virus, conﬁrming that ALV-A infection cannot occur in the
absence of Cys38 (data not shown). Envs with additional
substitutions at this position including Cys38Ala, Cys38Asp,
Cys38His, Cys38Lys, and Cys38Leu were also efﬁciently
processed and incorporated into virions, and each was also
completely defective (data not shown), further supporting the
conclusion that Cys38 is essential for ALV-A infection. Taken
together, evidence from both chemical and genetic-based
analyses indicates that Env Cys38-S
  is essential for ALV-A
infection.
Receptor Binding Is Not Cys38-Dependent
The role of Env Cys 38 in ALV-A infection was pursued. To
test whether this residue is necessary for SU binding to
receptor, immunoadhesins comprised of wild type or
Cys38Ser ALV-A SU fused in-frame to the constant region
of a rabbit immunoglobulin gamma chain (SUA-rIgG) were
produced in 293 cells, puriﬁed by protein A afﬁnity
chromatography, and used as ligands. The binding proﬁle
of Cys38Ser SUA-rIgG for 293-Tva cells is indistinguishable
from wild type SUA-rIgG protein (Figure 4). Neither the wild
type nor mutant ligands bound to 293 cells that do not
express Tva. These studies demonstrate that Cys38 is not
required for SU binding to Tva and suggest that the critical
Cys-S
 -dependent step(s) in ALV-A infection occur after
receptor binding.
Cys38 Is Not Required for Receptor-Dependent Low pH
Activation of TM
According to current models, exposure of the Tva-bound
Env to endosomal acid pH alters inter-subunit contacts and
Figure 2. Identification of NEM-Modified Cysteines in ALV-A Env by Mass
Spectrometry
(A) ALV-A was exposed to PMB or to NHS-Biotin in the presence or
absence of sTva. Env was immunoprecipitated with a polyclonal
antibody against the C-terminus of TM and biotinylated proteins were
detected with streptavidin-HRP. The positions of SU and TM are
indicated.
(B) The purified, deglycosylated SU used for mass spectrometry analysis
was quantified by SYPRO Ruby staining. The positions of SU and the
PNGase F enzyme used for glycosylation are indicated. Molecular weight
standards are in the left lane.
(C) Mass spectrometry identified three peptides from SU containing
NEM-modified cysteine residues (indicated by *).
(D) Vertical bars represent the cysteines in SU (two of the cysteines are
sequential just before position 292) and are positioned to scale. The host
range (HR) determinants 1 and 2 are indicated in light grey for reference.
The NEM-modified cysteines are numbered.
doi:10.1371/journal.ppat.0030198.g002
Figure 3. Analysis of Mutant Viruses for Infection and Env Incorporation
Each of the cysteines in ALV-A SU was individually mutated to serine.
Mutant viruses were produced in DF-1 cells, and the titer of each virus in
the supernatant was determined by endpoint dilution on DF-1 cells. Env
incorporation into virus was determined by immunoblot using an
antibody against the C-terminus of TM. Virus samples positive for capsid
by immunoblot were scored as positive or negative for Env.
doi:10.1371/journal.ppat.0030198.g003
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change that is coupled to membrane fusion. In particular,
the driving force for fusion is supplied by formation of a
highly stable helical bundle. The bundle is formed by a
hairpin turn in each TM such that the membrane proximal
segments fold back into the grooves on the outer surface of
an extended three-stranded coiled coil. Previous studies have
shown that helical bundle formation can be monitored by the
formation of an SDS-resistant TM oligomer [6,15,16]. We
used this assay to determine if receptor-induced bundle
formation is Cys38-dependent. Equal aliquots of puriﬁed wild
type and Cys38Ser virus particles were incubated with sTva
(100 nM) for 20 min on ice, 30 min at 37 8C, pH 8.0, and then
at 37 8C for 30 min at pH 5.0. The samples were neutralized,
reduced, and assayed by SDS-PAGE and immunoblot for
formation of TM oligomer. In the absence of sTva, exposure
of wild type or Cys38Ser virus particles to pH 5.0 did not
trigger formation of the SDS-resistant TM oligomer (Figure
5A). In the presence of sTva, signiﬁcant formation of TM
oligomer was observed upon exposure of wild type particles
to pH 5.0, and pH 5.0-induced oligomer formation was not
altered in the absence of Cys38. A second round of studies
was performed to assess the pH threshold for Tva-dependent
bundle formation. The proﬁles of TM oligomer formation as
a function of pH were similar for wild type and Cys38Ser
virus particles (data not shown).
To conﬁrm that the SDS-resistant oligomer is indicative of
a post-fusion conformation of TM, we tested the ability of the
R99 peptide inhibitor of ALV infection to block its
formation. The R99 peptide is derived from the HR2 segment
of TM and inhibits formation of the helical bundle by
competing with HR2 for binding to grooves on the outer
surface of the central three-stranded coiled coil [17,18].
Aliquots of wild type and Cys38Ser virus were incubated with
sTva for 20 min on ice, 30 min at 37 8C, pH 8.0, and then at 37
8C for 30 min at pH 5.0. Where indicated, 100 lM R99 was
included throughout all of the incubations. As a control,
additional samples were treated with R992XP, a peptide
containing two proline substitutions in R99 that does not
inhibit ALV-A infection [19]. The presence of R99 signiﬁ-
cantly inhibited the formation of the SDS-resistant TM
oligomer from both wild type and mutant viruses; whereas,
the R992XP peptide had no effect (Figure 5A). Therefore, we
conclude that the essential function of Cys38 in ALV-A
infection is independent of the receptor-primed, low pH-
triggered formation of the helical bundle in TM that is
necessary for membrane fusion.
Cys38 Is Not Required for Stability of ALV-Env
Previously, we identiﬁed 60 8C as the threshold temperature
to promote conversion of Env TM into the SDS-resistant
oligomer [6]. To determine if Cys38S
 is a determinant of Env
stability, the effect of Cys38Ser on the temperature threshold
for oligomer formation was measured. Virus particles were
incubated alone or in the presence of sTva (100 nM) at
temperatures from 45 8Ct o6 58C. After 30 min, the particles
were rapidly cooled to room temperature and the conforma-
tion of TM was analyzed. The ﬁndings demonstrate that the 60
8C threshold for heat-induced oligomer formation is not
altered in mutant Env (Figure 5B). sTva binding reduced the
threshold temperature for oligomer formation to 53 8C, and
this property was also not Cys38-dependent. These ﬁndings
indicate that Cys38-S
  is not a determinant of the stability of
native Env or the transition of receptor bound Env to the
bundle-containing conformation.
Tests for Cys38-S
 -Dependent Isomerase or Protease
Activity
Like ALV, a critical reactive thiol has also been identiﬁed
in MLV SU. Several studies have provided evidence that the
essential function of the critical MLV thiol is as a nucleophile
in receptor-induced isomerization of the disulﬁde bond
linking SU and TM [20,21]. A potential consequence of this
step is to release constraints imposed by SU on membrane
fusion by TM. To test if Tva binding induces isomerization
activity, the status of the SU-TM disulﬁde bond was analyzed
by immunoblot using anti-SU and anti-TM-speciﬁc anti-
bodies (Figure 6). The viral proteins recognized by these
antibodies in native particles under non-reducing conditions
are identical. Moreover, the proteins identiﬁed by these
antibodies under reducing conditions (þDTT) are distinct
and correspond to monomeric TM (34 kDa) and SU (80 kDa).
These ﬁndings conﬁrm that in virus particles, SU and TM are
covalently linked by a disulﬁde bond. Importantly, exposure
of virus particles to sTva and/or low pH did not alter the
composition of viral proteins identiﬁed by anti-SU and anti-
TM antibodies under non-reducing conditions. However,
analysis under reducing conditions conﬁrmed that sTva/low
pH triggered the conversion of TM into an SDS-resistant
oligomer (;75 kDa) that is indicative of helical bundle
formation. These ﬁndings demonstrate that SU and TM
remain covalently linked by a disulﬁde bond under con-
ditions in which Cys38-S
  is formed and TM is activated.
Isomerization of the disulﬁde bond linking SU to TM was also
not observed upon activation of TM by Tva/low pH treatment
of ALV Cys38Ser (data not shown). These ﬁndings indicate
that Cys38-S
  does not catalyze isomerization of the SU-TM
disulﬁde bond.
Figure 4. The Cys38Ser Mutation Does Not Alter the Affinity of SU for Tva
293 (open symbols) or 293-Tva cells (filled symbols) were incubated with
increasing concentrations of SU-A IgG (squares) or Cys38Ser SU-A IgG
(circles) for 1 h on ice. Cells were washed, stained with an Oregon green
488-conjugated goat anti-rabbit IgG, and analyzed by flow cytometry for
bound immunoadhesin.
doi:10.1371/journal.ppat.0030198.g004
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function as the active sites of proteases, including endosomal
cysteine proteases. Cleavage of Env by endosomal cysteine
proteases is required for Ebola and SARS infection [22,23].
The Env of these viruses, like that of ALV, are class I fusion
proteins. To test the hypothesis that Cys38-S
 is the active site
of an intrinsic cysteine protease that resides in ALV Env, we
measured ALV-A infection in the presence of E-64. E-64 is a
broadly active cysteine protease inhibitor that inactivates
host cysteine proteases and blocks infection by the Env GP of
Ebola virus [22]. E-64 treatment of virus before and/or during
exposure to Tva, low pH, and target membranes did not
detectably alter infectivity under conditions that blocked
Ebola GP-dependent entry (data not shown). This strongly
suggests that Cys38-S
  is not the active site of papain-like
protease activity that is required for infection.
ALV-A Association with Target Membranes
Because SU and TM remain covalently linked after
receptor/low pH activation of TM, we investigated whether
Cys38-S
  activity is necessary for virus association with target
membranes, perhaps by alleviating a steric block imposed by
SU. To address this question, the requirements for wild type
and mutant ALV-A particles to associate with liposome
targets was measured. Puriﬁed ALV-A particles were incu-
bated with liposomes in the presence of sTva for 20 min on
ice (to allow binding) and then for 30 min at 37 8C at pH 8.0.
The incubation mixture was divided, and each aliquot was
treated to adjust the pH from 7.4 to 5.0. After 30 min at 37 8C,
the pH of the sample was brought to 7.5 and formation of
virus-liposome complexes was assessed by density gradient
centrifugation. During centrifugation, the liposomes mi-
grated to the top of the gradient where they are visible and
virions (located by immunoblot for virus capsid p27)
remained at the bottom of the gradient (Figure 7A, fractions
6, 7, and 8). With the addition of sTva to the incubation (pH
6.0–7.4), a subset of the virions ﬂoated to the top of the
gradient with the liposomes (fractions 1, 2, and 3). This
observation is consistent with published studies reporting
that ALV-A association with liposomes is indicative of Tva-
induced insertion of the virus fusion peptide into the
liposome bilayer [24,25].
We found that the density of the virus-liposome complex
Figure 5. pH- and Receptor-Dependent TM Helical Bundle Formation Is Not Cys38-Dependent
(A) ALV-A (WT, top panel) or Cys38Ser (bottom panel) virus was incubated with or without sTva at the indicated pH in the presence or absence of the
R99 inhibitory peptide or a control, non-inhibitory R992XP peptide. Samples were reduced with DTT and resolved by SDS-PAGE without boiling.
Immunoblots were probed with an antibody against a peptide derived from the C-terminal segment of TM. TM monomer (,37 kDa) and trimer (.75
kDa) are shown.
(B) The Cys38Ser mutation does not alter the thermostability of Env. ALV-A (WT) or Cys38Ser viruses were incubated at the indicated temperatures in
the presence or absence of sTva. Samples were reduced with DTT and resolved by SDS-PAGE without boiling. Immunoblots were probed with the TM
antibody. Only the 90-kDa isoform of TM indicative of TM trimer is shown. Note that the reduced intensity of the TM oligomer from Env C38S at 65 8Ci s
an artifact of this gel and not representative.
doi:10.1371/journal.ppat.0030198.g005
Figure 6. The SU-TM Disulfide Bond Is Not Disrupted upon Env
Triggering by Receptor and Low pH
ALV-A was incubated with or without sTva at pH 8.0 for 20 min on ice
and then for 30 min at 37 8C at pH 5.0 (þacid) or pH 7.4 ( acid). Samples
were neutralized, exposed to 100 mM DTT (þDTT) or buffer ( DTT), and
incubated at room temperataure ( boil) or 100 8C( þboil) for 5 min prior
to SDS-PAGE and analysis by immunoblot for TM (left panel).
Immunoblots were then stripped with SDS/DTT and probed for SU
using the mc8C5 mAb (right panel). Note that both antibodies are more
sensitive for unreduced antigens.
doi:10.1371/journal.ppat.0030198.g006
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complexes at pH 5.0 (Figure 7A) or pH 5.5 (data not shown).
This effect of low pH was Tva-dependent and blocked by R99
peptide. Importantly, neither the Tva-dependent virus
association with liposomes nor the low pH-induced, R99-
sensitive increase in liposome-virus complex density was
Cys38-dependent (Figure 7B). These studies indicate that
receptor activation of the membrane-associated pre-hairpin
and R99 sensitive bundle-containing conformations of TM
are not dependent on Cys38-S
  activity.
Cell–Cell Fusion Is Cys38-Dependent
The role of Cys38 in fusion was tested further by measuring
Env-dependent cell–cell fusion and syncytia formation.
Permissive avian DF-1 cells expressing EGFP and either wild
type or Cys38Ser ALV-A were co-cultured with DF-1 cells
labeled with R18. After several hours at 37 8C to allow cell–
cell contact, cells were washed and incubated at pH 5.5 for 15
min to activate Env-Tva complexes and then analyzed by
microscopy and ﬂow cytometry for the formation of syncytia
indicative of cell–cell fusion. Exposure of this cell mixture to
pH 5.5 induced the formation of cell syncytia, which were
identiﬁed as large cells containing multiple nuclei and EGFP
positive cytoplasm surrounded by R18 positive membranes or
as double-positive cells by ﬂow cytometry (Figure 8A and data
not shown). In contrast, DF-1 cells producing ALV-A
Cys38Ser did not fuse with target cells after incubation at
pH 5.5. Similar results were obtained using 293-Tva cells that
express much higher levels of Tva than DF-1 cells (Figure 8B
and 8C). Additional experiments over a pH range of 5.0 to 8.0
conﬁrmed that the pH threshold for syncytia formation
mediated by wild type ALV-A Env is between pH 6.2 and 6.8
[15,26,27]; however, syncytia formation mediated by Cys38Ser
Env was not observed at any pH (data not shown). Moreover,
exposure of co-cultured cells to chlorpromazine, a cationic
agent that resolves hemifusion intermediates, did not rescue
the Cys38Ser-imposed defect (data not shown). Taken
together, these experiments conﬁrm that Env lacking Cys38
is defective in cell membrane fusion.
Thiol Alkylating Agents Mimic Low pH in Triggering Tva-
Dependent Helical Bundle Formation
The identiﬁcation of multiple reactive cysteines in ALV SU
using PMB modiﬁcation suggested that the thiol-dependent
mechanism is complex. As a ﬁrst attempt to determine the
functional relationships between these cysteines, we asked
whether the reactivity of Cys292 and Cys309 is dependent on
Cys38 function. Both wild type and Cys38Ser virus particles
were labeled with 1 mM PMB in the presence and absence of
sTva at neutral pH and then analyzed by blotting with
strepavidin-HRP. sTva-dependent PMB modiﬁcation of SU
was observed on wild type and mutant particles lacking Cys38
(data not shown). We also determined the conformation of
TM in these samples. Remarkably, we observed that that PMB
abrogated the low pH requirement for TM bundle formation
(Figure 9A). The chemically unrelated thiol-speciﬁc alkylating
agent, PEO-iodoacetyl biotin also mediates this effect (data
not shown). PMB-induced bundle formation is dependent on
Tva and does not require Cys38-S
  (Figure 9B). Although
indirect, these observations suggest that acid titration of
thiols on Cys292 and/or Cys309, mimicked by PMB modiﬁca-
tion, may be an essential part of the mechanism to deploy
TM. In addition, they show that Cys292/309-S
 activity is not
dependent on Cys38-S
  activity.
Discussion
The entry of retroviruses into cells is initiated by binding of
virus Env to cell surface receptor proteins. Each class of
retroviruses uses one or in some cases a few closely related
cell surface proteins as receptors. Although receptors have
Figure 7. Tva-Dependent Virus Association with Liposomes Is Not Dependent on Cys38-S
 
(A) ALV-A was incubated with or without sTva in the presence or absence of the R99 peptide at pH 8 (step 1). Samples were then shifted to the
indicated pH (step 2), incubated, neutralized, and separated by sucrose gradient. Gradient fractions were collected from the top (fraction 1), resolved by
SDS-PAGE, and analyzed by immunoblot for virus capsid (p27) using antisera against Rous sarcoma virus Prague C.
(B) ALV-A (WT) or Cys38Ser virus was incubated with or without sTva at pH 8, shifted to the indicated pH, incubated, neutralized, and then processed
and analyzed as in (A).
doi:10.1371/journal.ppat.0030198.g007
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proteins triggers infection is poorly understood. ALV is an
excellent model to study this problem because well-charac-
terized assays of receptor function have been established. The
hypothesis tested in this report was suggested by an analysis
of cysteine residues in Env. In the mature glycoprotein, a
single disulﬁde bond joins SU and TM, and SU-SU disulﬁde
bonds are not present; therefore, at least one of fourteen
cysteine residues in SU lacks a partner to form an intra-
molecular disulﬁde bond. We used thiol-reactive alkylating
agents to probe for the unpaired thiols in SU and found that
this reaction is Tva-dependent. This indicates that receptor
binding induces a conformational change in SU that creates a
CysS
  target that is inaccessible or unreactive in native Env.
This conclusion is consistent with previous reports that Tva
binding enhances the sensitivity of ALV SU to thermolysin
cleavage [28,29].
Remarkably, ALV infection was markedly inhibited by
alkylation of thiols on SU. Analysis of Env identiﬁed three Cys
residues with thiols that are targets and further studies of one
these residues, Cys38, was highly informative. Infection by
mutant ALV particles lacking Cys38 was never observed and
reversion of these particles to wild type did not occur during
prolonged cultivation of virus producing cells. Although
Cys38 is essential for infection, it has no apparent role in
maturation of pre-fusion Env. In addition, replacement of
Cys38 with serine did not alter the afﬁnity of SU for Tva or
the temperature threshold for heat-induced folding of virus
TM into the SDS-resistant oligomers containing the helical
bundle. The temperature threshold for heat-induced bundle
formation is a particularly sensitive indicator that the
intersubunit interactions that stabilize the metastable pre-
fusion conformation of Env are not dependent on Cys38 [2,6].
Based on these studies, we conclude that an essential function
of receptor binding in ALV infection is the formation of
Cys38-S
 . Determination of the redox state of the Cys thiols
in ALV Env before and after binding to Tva is needed to
ascertain the relationship between receptor binding and
Cys38-S
  formation. The most straightforward possibility is
that Cys38-S
  is present in mature Env, but is inaccessible or
unreactive to thiol alkylating agents. Alternatively, Cys38-S
 
may be the product of intramolecular disulﬁde isomerization
initiated by another Cys-S
  in SU, including Cys292 and/or
Cys309. Because the number and distribution of cysteine
residues including Cys38 is conserved in Envs of ALV
subgroups B, D, E and J, receptor-induced formation of
reactive Cys-S
 residues in SU may be an essential property of
all alpharetroviruses.
The absence of a detectable inﬂuence of Cys38 on Env
maturation and the receptor-dependence of reactive thiol
strongly suggests that Cys38-S
 mediates a post-receptor step.
Current models indicate that the critical post-receptor step is
activation of TM [1–4,8]. After Env maturation and cleavage,
the conformation of the newly formed TM subunit is
metastable, and membrane fusion and infection are coupled
to completion of folding [2,6]. From studies of inﬂuenza HA2,
HIV gp41 and transmembrane subunits of other class I Envs,
two well-deﬁned elements of this conformational change are
exposure and insertion of the N-terminal fusion peptide into
the target membrane and formation of the helical bundle.
The role of Tva binding in regulating these steps in ALV
infection has been the subject of previous investigation [25].
Tva binding markedly enhanced the reactivity of ALV
particles with an antibody that recognizes the TM fusion
peptide and strongly promotes the association of these
particles with liposomes. The non-covalent, hydrophobic
nature of this association is indicated by its resistance to 1
M NaCl, 10 mM sodium carbonate, and 4 M urea [24,25]. Tva
binding to SU is also necessary to prime the action of low pH
to trigger membrane fusion and infection. Both fusion and
infection are closely correlated with helical bundle formation
[15], including sensitivity to inhibition by the R99 peptide
derived from the HR2 segment of TM [16–18]. Using these
well-characterized assays to probe receptor function, we ﬁnd
Figure 8. The Cys38Ser Mutation Blocks Env-Mediated Fusion
(A) DF-1 cells producing wild type or Cys38Ser Env virus (expressing EGFP) were cultured with R18 labeled DF-1 cells. Co-cultured cells were incubated
at the indicated pH, and images were taken. Cell–cell fusion (syncytia formation) is indicated by large, multi-nucleated cells with diffuse EGFP
fluorescence and R18 positive membranes.
(B) As in (A), except virus producing cells were co-cultured with 293-Tva cells.
(C) Cell cultures from B were dissociated with versene and analyzed by flow cytometry for R18 and EGFP expression. Shown is the percentage of double
positive cells, indicative of cell–cell fusion, for each condition.
doi:10.1371/journal.ppat.0030198.g008
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membranes nor assembly of TM into helical bundles is Cys38-
S
 -dependent.
Analysis of the migration of virus/liposome complexes in
sucrose density gradients provided another parameter to
investigate the potential role of Cys38-S
  in helical bundle
formation. In this assay, brief exposure to pH 5.0 or to 5.5 was
associated with apparent increase in the density of sTva-
induced virus-liposome complexes, perhaps due to a reduc-
tion in the number of liposomes associated with each particle.
Alternatively, this change in density may reﬂect the dissoci-
ation of capsid from the liposome-associated particle. This
increase in liposome-associated particle density induced by
acid pH is dependent on bundle formation, since the R99
inhibitor of infection speciﬁcally blocked the acid pH-
dependent shift in density. Although the molecular basis for
the shifting mobility of virus particles is unclear, it is another
parameter that is closely correlated with bundle formation
and infection, yet conserved in the absence of Cys38-S
 .
Taken together, these studies support the conclusion that
activation of TM is not the essential function of Cys38-S
  in
infection.
What are possible Cys38-S
  -dependent steps in Env
function that are not accounted for in current models of
fusion? One possibility is that SU might sterically interfere
with correct insertion of TM into the membrane unless
removed. For HIV, gp120 is non-covalently linked to gp41,
which may facilitate the displacement of gp120 from the site
of fusion [30]. Like ALV, MLV SU is tethered to TM by a
single disulﬁde bond, but receptor-induced reduction of this
bond is closely correlated with infection [20,31]. In contrast,
isomerization of the ALV SU-TM disulﬁde bond was not
induced by binding to Tva or subsequent activation of TM—
either in the presence or absence of Cys38-S
 . So, a simple
model of SU release is not supported. Moreover, a strict
requirement for the release of the membrane distal subunit
for Type I Env infection is excluded because the covalent
interaction between HA1 and HA2 is not disrupted during
inﬂuenza infection [8]. However, it is possible that an
unidentiﬁed host factor functions in concert with Cys38-S
 
to promote infection by disrupting the covalent association
between SU and TM.
A second possibility is that the absence of Cys38-S
  results
in changes in TM activation that are not detected by our
assays. For example, the fusion-active pathway could be
dependent upon synchronous Env activation mediated by
Cys38-S
 . Thus, a decrease in the rate of helical bundle
formation in the mutant Env could shunt TM into a dead-end
pathway that does not result in fusion. If true, the difference
in active and dead-end pathways must be subtle, since Cys38
did not measurably alter the threshold for thermal activation
of Env/Tva complexes. Future studies directed at comparing
the structure and kinetics of Env activation in native and in
Cys38-deﬁcient particles are needed.
A straightforward explanation for why Cys-38-S
  is
essential is that it mediates a key step that occurs after
bundle formation. Previous studies revealed close spatial and
temporal relationships between bundle assembly and mem-
brane merger/pore formation [26,32]. In particular, the late
steps in this process to form a structure analogous to the N
cap of inﬂuenza HA2 may be Cys38-dependent, but not
detectable in our assay [33]. In addition, it has been noted
that most newly formed pores are small and rapidly close.
Indeed, there is a substantial barrier to pore enlargement due
to entropic constraints on lipids at the pore edges [34].
Therefore, an additional possibility is that Cys38-S
  activity
promotes expansion of the nascent pore, possibly through
direct reaction with the membrane. Although speculative, this
hypothesis is testable using more sensitive measures of lipid
and content mixing. However, the failure of chlorpromazine
to rescue the fusion defect of the Cys38Ser mutant suggests
that fusion is blocked prior to hemifusion.
The observation that thiol alkylation inhibits infection is
consistent with an intrinsic enzymatic activity in SU. In
extracellular proteins, the majority of functionally important
thiolates form the active sites of enzymes, and cysteine-
alkylating agents are potent, irreversible inhibitors of these
enzymes. Therefore, an alternative approach to identify the
role of Cys38-S
  in infection is to identify its substrate. Based
on analogy to MLV [20] and pestiviruses [35], a leading
candidate is the disulﬁde bond linking SU and TM. As
mentioned above, we were unable to detect isomerization of
this bond under conditions where Tva-induced reactive thiols
were present. It remains possible that the presence of an
additional unidentiﬁed host factor is necessary for activation
of an intrinsic thiol isomerase activity. Alternatively, Cys38-S
 
may participate in isomerization of intramolecular disulﬁde
Figure 9. Thiol-Specific Alkylating Agent PMB Mimics Low pH in Triggering Receptor-Dependent TM Helical Bundle Formation Independently of Cys38-
S
  Function
(A) ALV-A was incubated with or without the indicated concentrations of sTva for 20 min on ice at pH 8.0. Samples were then exposed to 1 mM PMB (þ)
or buffer ( ) at the indicated pH for 30 min at 37 8C. Samples were neutralized, reduced, and analyzed by immunoblot for TM as in Figure 6. TM
monomer (,37 kDa), trimer (.75 kDa), and higher order (.170 kDa) species are shown.
(B) Cys38Ser virus was analyzed as in (A).
doi:10.1371/journal.ppat.0030198.g009
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alignment of TM activation for efﬁcient fusion.
Another possibility is that Cys38-S
  is the active site of
intrinsic Env protease activity. Indeed, a role for host cysteine
protease activity is identiﬁed for ﬁlovirus and coronavirus
infection [22,23]. We found no effect of a broadly active
cysteine protease inhibitor, E-64, on infection under con-
ditions in which Ebola infection was blocked. We also were
unable to identify cleavage products of viral proteins induced
by Env activation. However, this hypothesis remains open
because not all cysteine proteases are sensitive to E-64. More
extensive investigation of the integrity of Env upon fusion
with cells using radiolabeled proteins may identify cleavage
products that were not generated or apparent in our in vitro
studies. A third possibility is that Cys-38-S
  is part of the
active site of phospholipase or forms thioester adducts with
fatty acids in the target membrane. Phospholipase activity has
been observed in membrane disruption by parvovirus [36].
And, the formation of thioester adducts could potentially
stabilize nascent pores formed by TM.
A key to future studies may be in understanding the
relationship of Cys38-S
  to other thiols. We found two other
receptor-induced thiolates at positions 292 and 309. The
reactivity of these thiolates is independent of Cys38-S
 , since
Tva-dependent modiﬁcation occurred in the absence of
Cys38. An unusual property is that NEM modiﬁcation of
these residues induced bundle formation. Unfortunately,
their role is less well deﬁned since mutants were unable to
fold and could not be studied. This suggests that, unlike
Cys38, they participate in one or two structurally important
disulﬁde bonds (either by being bonded to each other or to
unidentiﬁed partners), and that their reactivity is generated
by reduction of these bonds. The thiolate groups of these
residues may be titrated by low pH as part of TM activation,
since both low pH and NEM modiﬁcation are correlated with
bundle formation. These studies provide more evidence that
in the absence of Cys38-S
 , bundle formation alone is not
sufﬁcient for fusion and infection. Further studies are needed
to clarify the states of the thiols in SU in the pre- and post-
receptor states to fully understand the role of Cys38-S
 
activation in infection.
Materials and Methods
Cell lines and cysteine-reactive reagents. Human 293 cells were
obtained from the ATCC. Avian DF-1 cells that produce a
replication-competent ALV-A encoding enhanced green ﬂuorescent
protein (RCASBP(A)-EGFP, DF-1-ALV-A), a 293-derived cell line that
expresses Tva (293-Tva or 2.1), and a 293-derived cell line that
expresses mCAT-1 (293-mCAT) have been previously described [15].
These cells were propagated in Dulbecco’s modiﬁed Eagle’s medium
supplemented with 10% fetal bovine serum, 4 mM L-glutamine, 100
U of penicillin/ml, and 100 lg of streptomycin/ml at 37 8Ci n5 %C O 2.
The growth medium of 293-Tva cells was supplemented with 1 lg/ml
puromycin.
N-ethyl maleimide (NEM) was obtained from Sigma. PEO-
maleimide biotin (PMB) and Sulfo-NHS-biotin (SNB) were obtained
from Pierce.
Antibodies. Afﬁnity puriﬁed, polyclonal rabbit antisera against the
C-terminus of TM (TM-1) has been described previously [15]. Goat
antisera against Tween/ether disrupted Rous sarcoma virus Prague C
(74S-389) was originally made at the NCI and distributed through
Viromed. The anti-SU mAB mc8C5 was obtained from the hybridoma
facility at the University of Alabama at Birmingham [37].
Virus and sTva production. DF-1-ALV-A cells were grown in roller
bottles with extended surface area in 50 mls of medium. Supernatants
were harvested twice a day, and individual collections were pooled
until 1 L of supernatant accumulated. Supernatants were pre-cleared
by low speed centrifugation and ﬁltered through 0.45-lm ﬁlters to
remove cells and cell debris. Aliquots were frozen for later use. Virus
was puriﬁed and concentrated by pelleting through a sucrose cushion
(15% sucrose in 10 mM HEPES, 130 mM NaCl [pH 8.0]) for 1 hour at 4
8C at 113,000 x g (max) in a SW28 swinging bucket rotor (Beckman).
The virus pellet was re-suspended in HN buffer (10 mM HEPES, 130
mM NaCl [pH 8.0]) for 1 hour at 4 8C before use.
Plasmids encoding Friend MLV Env, MLV gag-pol, and MLV LTR-
EGFP have been described [15]. To generate MLV virions, equal
amounts of these plasmids were transfected into 293 cells using
Polyfect (Qiagen) according to the manufacturer’s instructions. To
generate chimeric virions with ALV-A Env on MLV cores, a
previously described plasmid encoding ALV-A Env (pAB6-Env A)
was substituted for the MLV Env-encoding plasmid in the trans-
fection [15].
sTva was puriﬁed from E. coli as previously described [6].
Inhibition of infection by PMB. Virus was concentrated from
supernatants by two cycles of ultracentrifugation through a 15%
sucrose cushion in HN buffer, resuspended in a small volume of HN
for 1 h at 4 8C, and incubated with 10 lM sTva to allow binding. PMB
was dissolved in HN buffer and diluted into the virus/sTva samples to
the indicated ﬁnal concentrations. The pH of the concentrated
solutions (pH 8.0) was veriﬁed prior to addition to the virus. Samples
were incubated at 37 8C for 30 min, cooled on ice, serially diluted in
growth medium supplemented with 40 mM HEPES, and added on ice
to 12-well plates of 293-mCAT (for MLV infection) or 293-Tva cells
(for ALV-A and chimeric ALV/MLV infections) that were pre-chilled
to 4 8C. Plates were centrifuged for 2 hours at 1640 x g in an Allegra
6R centrifuge (Beckman) at 4 8C and then centrifuged for an
additional 30 minutes while the temperature was gradually raised to
35 8C as previously described. Plates were then transferred to a 37 8C
incubator and cultured for 36–48 hours before being ﬁxed in
paraformaldehyde and analyzed by ﬂow cytometry for EGFP
expression.
TM trimer formation assay and liposome preparation. Pelleted
virus was resuspended in a small volume of HN buffer supplemented
with 1 mM CaCl2 (HNC) and incubated for 20 minutes on ice with the
indicated concentration of sTva to allow binding, for 30 min at 37 8C
at pH 8.0, and then for 30 min at 37 8C at pH 5.0 or 8.0 in pre-
determined volumes of 100 mM Tris-acetate or Tris-HCl. Where
indicated, 1 mM PMB was added to the samples after the 20 min
incubation with sTva on ice. The samples were then neutralized with
1 M HEPES, pH 8.0, lysed with 1% SDS, and incubated for 10 minutes
at 37 8C. Samples were reduced with 100 mM DTT and analyzed by
immunoblot after SDS-PAGE on 13% polyacrylamide gels with an
antibody against the carboxyl-terminus of TM as described previously
[6].
To study the effects of the R99 peptide inhibitor of ALV-A
infection on trimer formation, R99 (FNLSDHSESIQKKFQLM-
KEHVNKIG) and R992XP (FNLSDHSESPQKKPQLMKEHVNKIG)
were synthesized to .95% purity by Research Genetics (Invitrogen)
with N-terminal acetylation and C-terminal amidation. Liposomes
were created from a mixture of a 1:1:1:1.5 molar ratio of
phoshatidylcholine, phosphatidylethanolamine, sphingomyelin, and
cholesterol. Lipids were obtained from Avanti Polar Lipids (Alabast-
er, AL), mixed in chloroform, dried under argon, and lyophilized in
glass tubes. The mixture was then rehydrated with HN buffer by
shaking for 1 hour, sonicated in a water bath sonicator for 10 min,
and extruded 25 times with an Avanti mini-extruder using a 100 nm
pore size ﬁlter. Virus was mixed with liposomes with or without 100
nM sTva on ice. The R99 and R992XP peptides were dissolved in HN
buffer, added to the virus/liposome/sTva mixtures to a ﬁnal
concentration of 100 lM, and incubated at pH 8 for 20 min at 37
8C. Samples were then adjusted to the indicated pH and incubated for
30 min at 378C prior to neutralization and analysis as described
above.
To study the integrity of the SU-TM disulﬁde bond, samples were
incubated with or with 100 nM sTva at pH 8.0 for 20 min on ice and
then for 30 min at 37 8C at pH 5.0 or pH 7.4. Samples were
neutralized, exposed to 100 mM DTT or buffer, and incubated at RT
or 100 8C for 5 min prior to SDS-PAGE and analysis by immunoblot
for TM. Immunoblots were then stripped with SDS/DTT and probed
for SU using the mc8C5 mAb.
To study the formation of the TM trimer induced by PMB, virus
was incubated with or without the indicated concentrations of sTva
for 20 min on ice at pH 8.0. Samples were then exposed to 1 mM PMB
or buffer at the indicated pH for 30 min at 37 8C. Samples were
neutralized and analyzed by immunoblot for TM as above.
Modiﬁcation of SU by PMB. Virus was concentrated from super-
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cushion in HN buffer, resuspended in a small volume of HN for 1 h at
4 8C, and incubated with 1.5 lM sTva to allow binding. PMB or SNB
were dissolved in HN buffer and diluted into the virus/Tva samples to
a ﬁnal concentration of 1 mM. After incubation for 30 min at 37 8C,
samples were quenched with a molar excess of cysteine-HCl (PMB) or
glycine (SNB). Samples were lysed with NP-40 and immunoprecipi-
tated with the antibody against the C-terminus of TM using Protein A
beads (Pierce). Immunoprecipitated proteins were eluted from the
beads by boiling in gel loading dye containing DTT, resolved by SDS-
PAGE, transferred to nitrocellulose membranes, and probed for
biotin with streptavidin-HRP.
Mass spectrometry analysis of SU. Concentrated ALV-A was
thawed on ice, and sTva was added to 5 lM. After incubation for
20 min on ice, NEM was added to 10 mM and incubated for 1 h at 37
8C. The sample was then concentrated by trichloroacetic acid
precipitation and washed twice with cold acetone. The pellet was
dried, re-suspended in SDS-PAGE loading dye with DTT, resolved by
SDS-PAGE, and transferred to PVDF. The PVDF fragment containing
the glycosylated SU was excised from the membrane, dried, and then
boiled for 10 min in denaturing buffer (0.5% SDS with 1% b-
mercaptoethanol). PNGase F (New England Biolabs) was added and
incubated for 1 h at 37 8C. The deglycosylated sample was resolved by
a second round of SDS-PAGE, quantiﬁed by SYPRO Ruby (Invitro-
gen) stain against a standard curve, excised from the gel, and
submitted for analysis. The SU sample was reduced, alkylated, and
digested with protease at the Harvard Microchemistry Facility.
Samples were analyzed by microcapillary reverse-phase HPLC
nano-electrospray tandem mass spectrometry on a Thermo Finnigan
LCQ DECA XP Plus quadropole ion trap mass spectrometer.
Mutagenesis and production of stable cell lines. Amino acid
substitutions in ALV-A Env were generated by PCR mutagenesis
using overlapping primers. For each amino acid substitution, at least
two base pairs of the codon were changed to minimize the chance of
reversion. Initial PCR products were subcloned into a shuttle vector
comprised of a Kpn I/Sal I restriction fragment of RCASBP(A)-EGFP
in the pAB6-Env A vector, and mutagenesis was conﬁrmed by
sequencing. This restriction fragment comprises the entire Env ORF
including some 59 UTR sequence. A Kpn I/Stu I restriction fragment
from the shuttle vector was then cloned into the RCASBP(A)-EGFP
plasmid, and the presence of the mutation was again conﬁrmed by
sequencing. Mutant RCASBP(A)-EGFP plasmids were transfected into
DF-1 cells with Superfect (Qiagen) according to the manufacturer’s
instructions to generate virus. Transfection was conﬁrmed by EGFP
expression. Replication-competent viruses were identiﬁed by mon-
itoring the spread of acquired EGFP expression in the transfected
cultures. Single cell clones of cells expressing noninfectious virus
were produced by co-transfecting the RCASBP(A)-EGFP plasmid
bearing the mutation with pBABE-puro, a puromycin expression
plasmid. Cells were selected in puromycin (1 lg/ml), and colonies
expressing EGFP were isolated and expanded. EGFP-positive clones
were periodically tested to conﬁrm the noninfectious phenotype by
co-culture with uninfected DF-1 cells or by analyzing DF-1 cells
exposed to ﬁltered supernatant for acquired EGFP expression. The
presence of the mutation was again conﬁrmed by PCR and
sequencing of the provirus in the transfected cells. For replication-
competent mutant viruses, the mutation was conﬁrmed in cells
infected with ﬁltered virus from the initially transfected cells to verify
that the mutation could be stably transmitted.
Virus titers in the supernatant of cells producing mutant viruses
were determined by endpoint dilution on DF-1 cells. Env incorpo-
ration of mutant virus puriﬁed from supernatant by centrifugation
(as above) was determined by SDS-PAGE and immunoblot using the
antibody against the carboxyl-terminus of TM.
SU-A IgG binding assay. The SU-A IgG expression construct was a
gift from J. A. T. Young (Salk Institute, La Jolla, CA) [38]. The
Cys38Ser mutation was engineered in this vector by PCR mutagenesis
using overlapping primers and veriﬁed by sequencing. 293 cells were
transfected with the SU-A IgG and Cys38Ser SU-A IgG constructs
using Polyfect (Qiagen) following the manufacturer’s instructions.
Eighteen hours after transfection, cells were washed twice with PBS,
and the media was replaced with media that had been pre-cleared of
IgG by two rounds of afﬁnity puriﬁcation using an immobilized
protein A column (Pierce). Media was collected after 24 hrs, ﬁltered
through a 0.45 lm ﬁlter, and frozen. To isolate SU-A IgG, ﬁltered
supernatants were thawed and applied to an immobilized protein A
column (Pierce). The column was washed with 20 mM sodium
phosphate pH 7 and eluted with 0.1 M citric acid pH 3.0. Fractions
were immediately neutralized with 1.5 M Tris pH 8.8. Peak fractions
were identiﬁed by immunoblot, pooled, dialyzed against PBS, and
concentrated using a Microcon device according to the manufac-
turer’s instructions (Amicon). Puriﬁed, concentrated protein was
quantiﬁed by SYPRO Ruby stain against a standard curve.
To determine the binding of SU-A IgG to Tva, 293 (negative
control) or 293-Tva cells were incubated with increasing concen-
trations of SU-A IgG or Cys38Ser SU-A IgG for 1 hour on ice in PBS/
1% FBS. Cells were washed twice with PBS/1% FBS and incubated
with an Oregon green 488-conjugated goat anti-rabbit IgG (Invi-
trogen) for 1 hr on ice. Cells were washed twice and analyzed by ﬂow
cytometry.
Liposome association assay. Liposomes were created as described
above. Pelleted virus was mixed with liposomes with or without 100
nM sTva and incubated for 45 min on ice. The R99 peptide was
dissolved in HN buffer, added to the virus/liposome/sTva mixtures to
a ﬁnal concentration of 100 lM, and incubated at pH 8 for 30 min at
37 8C. Samples were then adjusted to the indicated pH, incubated for
30 min at 37 8C, and neutralized with 1 M Hepes. Neutralized samples
were mixed with an equal volume of 80% sucrose in HNC,
transferred to an ultracentrifuge tube (170 ll sample volume), and
overlaid with 30% sucrose (340 ll) and 15% sucrose (100 ll) in HNC.
Samples were centrifuged at 48C for 1 hr at 179,000 x g (ave) using a
TLA 100.1 rotor (Beckman Coulter). Fractions were collected from
the top of the gradient, resolved by reducing SDS-PAGE, and
analyzed by immunoblot using antisera against Rous sarcoma virus
Prague C.
Syncytia formation assay. Cultured monolayers of DF-1 or 293-Tva
cells were stained with 0.8 lg/ml R18 in growth media for 1 hr at 37
8C. Labeled cells were washed with PBS, and DF-1 cells expressing
Cys38Ser Env or wild type RCASBP(A)-EGFP were harvested with
versene, co-plated with the R18 labeled cells, and incubated for 2 h at
37 8C to form monolayers. The cells were washed twice with PBS, and
then incubated with PBS at the indicated pH values for 15 min at 37
8C. Cells were then washed twice with PBS and returned to normal
growth media. After an additional 30 min to 1 h incubation at 37 8C,
images were taken, and syncytia were identiﬁed as large, multi-
nucleated cells with diffuse EGFP ﬂuorescence and R18 positive
membranes. Parallel samples were harvested with versene and
analyzed by ﬂow cytometry for EGFP and R18.
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